Market cap
$513 Mln
Revenue (TTM)
$546 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 3.86 | 41.22 | 35.37 | 25.89 | 23.23 |
| EBIT | 90.02 | 96.02 | 32.42 | 2.08 | -237.88 |
| Net Profit | 66.81 | 87.28 | 32.39 | 3.68 | -242.86 |
| EPS | 66.92 | 99.04 | 94.69 | 24.51 | 12.02 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -14.31 | -18.76 | -6.60 | -9.84 | -14.53 |
| Net Margin
| -- | -2.77 | -7.97 | -- | -- |
| Return on equity
| 231.21 | 135.45 | -- | 999.19 | -213.36 |
| Return on Capital
| -46.60 | -30.97 | -- | -56.45 | -42.62 |
| Return on Assets
| -35.02 | -22.62 | -18.47 | -35.93 | -33.86 |
| Debt to Equity (x)
| -- | -- | -4.83 | -6.60 | 34.31 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
-56.45
|
-42.62
|
-40.71
|
0.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
999.19
|
-213.36
|
-92.20
|
0.13
|
|
Peer Median
|
7.96
|
--
|
--
|
--
|
--
|
ROA
-18.47
Lower than Peers by 20.24
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
-18.47
|
-35.93
|
-33.86
|
-35.28
|
0.07
|
|
Peer Median
|
1.76
|
--
|
--
|
--
|
--
|
EBIT Margin
-6.60
Lower than Peers by 13.19
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
-6.60
|
-9.84
|
-14.53
|
-18.55
|
-28.52
|
|
Peer Median
|
6.60
|
--
|
--
|
--
|
--
|
Net Margin
-7.97
Lower than Peers by 10.98
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
-7.97
|
-12.06
|
-16.44
|
-25.62
|
0.04
|
|
Peer Median
|
3.01
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
35.37
Higher than Peers by 25.62
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
35.37
|
0.28
|
0.21
|
0.28
|
0.24
|
|
Peer Median
|
9.75
|
--
|
--
|
--
|
--
|
EBIT Growth
32.42
Higher than Peers by 15.43
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
32.42
|
13.48
|
4.96
|
16.47
|
-58.67
|
|
Peer Median
|
16.99
|
--
|
--
|
--
|
--
|
Net Profit Growth
32.39
Higher than Peers by 15.01
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
32.39
|
6.27
|
22.16
|
-54,750.00
|
101.39
|
|
Peer Median
|
17.38
|
--
|
--
|
--
|
--
|
EPS Growth
94.69
Higher than Peers by 78.32
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
94.69
|
0.93
|
0.24
|
-637.63
|
1.01
|
|
Peer Median
|
16.37
|
--
|
--
|
--
|
--
|
Book Value Growth
-124.33
Lower than Peers by 129.69
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
-124.33
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.36
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-4.83
Lower than Peers by 5.22
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
-4.83
|
-6.60
|
34.31
|
2.10
|
0.88
|
|
Peer Median
|
0.39
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.45
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
-0.45
|
-0.46
|
1.89
|
0.11
|
0.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.47
Lower than Peers by 0.05
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
1.47
|
1.59
|
2.15
|
4.12
|
4.39
|
|
Peer Median
|
1.53
|
--
|
--
|
--
|
--
|
Quick Ratio
1.17
Lower than Peers by 0.25
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
1.17
|
1.35
|
1.96
|
3.73
|
4.08
|
|
Peer Median
|
1.42
|
--
|
--
|
--
|
--
|
Interest Coverage
-4.71
Lower than Peers by 8.15
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
-4.71
|
-4.39
|
-7.63
|
-8.88
|
-17.64
|
|
Peer Median
|
3.44
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
10.89
Lower than Peers by 2.51
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
10.89
|
11.80
|
12.37
|
13.23
|
16.01
|
|
Peer Median
|
13.40
|
--
|
--
|
--
|
--
|
Asset Turnover
2.32
Higher than Peers by 1.54
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
2.32
|
2.98
|
2.06
|
1.38
|
1.09
|
|
Peer Median
|
0.78
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
39.23
|
42.52
|
46.94
|
44.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
11.53
|
12.76
|
15.83
|
14.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
28.91
|
20.85
|
16.42
|
22.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
21.85
|
34.43
|
46.35
|
36.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
-59.60
|
-0.36
|
-1.80
|
929.12
|
|
Peer Median
|
33.16
|
--
|
--
|
--
|
--
|
Price / Book Value
0.76
Lower than Peers by 2.77
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
0.76
|
-229.76
|
6.51
|
2.63
|
1.15
|
|
Peer Median
|
3.54
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
8.53
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
8.53
|
-86.60
|
-1.90
|
-3.44
|
-2.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
513
Higher than Peers by 150
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
513
|
--
|
--
|
--
|
--
|
|
Peer Median
|
363
|
--
|
--
|
--
|
--
|